Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၀.၂၁%
၁,၀၉၁.၅၁
-၂.၃၀
-၀.၂၁%
—၁,၀၉၃.၈၁၁,၀၉၆.၅၂၁,၁၀၀.၂၂၁,၀၉၁.၅၁——
SIXC
Communications
SIXC
Communications
SIXC
+၀.၂၂%
၆၁၀.၁၁
+၁.၃၄
+၀.၂၂%
—၆၀၈.၇၇၆၀၈.၇၇၆၁၂.၉၇၆၀၈.၇၇——
SIXE
Energy
SIXE
Energy
SIXE
-၁.၃၄%
၁,၂၃၇.၉၈
-၁၆.၈၃
-၁.၃၄%
—၁,၂၅၄.၈၁၁,၂၅၃.၀၁၁,၂၅၃.၈၇၁,၂၂၆.၃၃——
SIXI
Industrials
SIXI
Industrials
SIXI
-၀.၉၃%
၁,၇၄၄.၇၁
-၁၆.၄၀
-၀.၉၃%
—၁,၇၆၁.၁၁၁,၇၆၄.၂၇၁,၇၆၆.၈၈၁,၇၄၄.၇၁——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၃၇%
၆၄၀.၁၈
-၂.၄၀
-၀.၃၇%
—၆၄၂.၅၈၆၄၄.၈၇၆၄၈.၄၈၆၄၀.၁၈——
SIXR
Staples
SIXR
Staples
SIXR
-၀.၁၈%
၈၄၉.၅၈
-၁.၅၅
-၀.၁၈%
—၈၅၁.၁၃၈၅၅.၆၆၈၅၈.၇၅၈၄၅.၅၆——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၂၃%
၂၁၇.၄၈
-၀.၅၀
-၀.၂၃%
—၂၁၇.၉၈၂၁၇.၉၈၂၁၈.၆၅၂၁၆.၈၈——
SIXT
Technology
SIXT
Technology
SIXT
+၁.၅၂%
၃,၂၆၀.၆၉
+၄၈.၈၆
+၁.၅၂%
—၃,၂၁၁.၈၃၃,၂၂၇.၂၁၃,၂၆၈.၃၈၃,၂၂၆.၅၅——
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၆၉%
၉၄၂.၄၅
-၆.၅၃
-၀.၆၉%
—၉၄၈.၉၈၉၄၈.၅၈၉၅၇.၈၃၉၄၁.၉၇——
SIXV
Health care
SIXV
Health care
SIXV
-၀.၅၂%
၁,၄၆၆.၈၀
-၇.၇၂
-၀.၅၂%
—၁,၄၇၄.၅၂၁,၄၇၉.၀၃၁,၄၈၁.၀၄၁,၄၆၆.၈၀——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၂၂%
၂,၃၉၇.၅၀
+၅.၃၈
+၀.၂၂%
—၂,၃၉၂.၁၂၂,၃၉၆.၉၅၂,၄၂၁.၂၂၂,၃၈၂.၃၂——
4502:TYO
Takeda Pharmaceutical Co Ltd
၅,၂၃၉.၀၀ JP¥
-၀.၅၉%
(-၃၁.၀၀) 1D
မေ ၁, GMT+၉ ၁၅:၃၀:၀၀  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4502...
Open
၅,၂၆၀ JP¥
High
၅,၂၆၀ JP¥
Low
၅,၁၉၁ JP¥
Mkt. cap
ဋေ ၈.၃၄ သိန်း
Avg. vol.
၄.၃၇ သန်း
Volume
၂.၆၃ သန်း
Dividend
၃.၇၈%
Quarterly dividend
၄၉ JP¥
Ex dividend date
၂၀၂၅ စက် ၂၉
P/E ratio
၇၂.၅၀
52-wk high
၆,၀၃၃ JP¥
52-wk low
၄,၀၀၀ JP¥
EPS
၇၂ JP¥
Shares outstanding
၇၈.၄၅ ကုဋေ
No. of employees
၅ သောင်း
News stories
From sources across the web
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၉ နာရီ
Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Japanese Stocks Amid Restructuring Drive?
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၂၁ နာရီ
Takeda’s SPOTLITE Study Wraps Up, Sharpening the View on Complex Fistula Care
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၂ ရက်
A Look At Takeda Pharmaceutical (TSE:4502) Valuation As Shares Soften Despite Strong Longer Term Returns
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ ရက်
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees၄.၇၅ သောင်း
Founded၁၇၈၁ ဇွန် ၁၂
Headquarters-
Sector-
Websitetakeda.com
Last report
၂၀၂၆ ဇန် ၂၉
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -JPY
Revenue / Estimate
ဋေ ၁.၁၉ သိန်း/ (ဋေ ၁.၂၀ သိန်း est.)JPY
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
၂၀၂၅ မတ်
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
ဋေ ၁.၀၅ သိန်း
ဋေ ၁.၁၁ သိန်း
ဋေ ၁.၁၁ သိန်း
ဋေ ၁.၁၉ သိန်း
Cost of goods sold
ဋေ ၃.၇၃ သ
ဋေ ၃.၈၅ သ
ဋေ ၃.၈၀ သ
ဋေ ၄.၀၁ သ
Cost of revenue
ဋေ ၃.၇၃ သ
ဋေ ၃.၈၅ သ
ဋေ ၃.၈၀ သ
ဋေ ၄.၀၁ သ
Research and development expenses
ဋေ ၂.၁၆ သ
ဋေ ၁.၄၄ သ
ဋေ ၁.၆၁ သ
ဋေ ၁.၇၅ သ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၂.၉၆ သ
ဋေ ၂.၅၆ သ
ဋေ ၂.၅၄ သ
ဋေ ၂.၈၃ သ
Operating expense
ဋေ ၅.၅၇ သ
ဋေ ၅.၃၅ သ
ဋေ ၅.၆၃ သ
ဋေ ၆.၆၁ သ
Total operating expenses
ဋေ ၉.၃၀ သ
ဋေ ၉.၂၀ သ
ဋေ ၉.၄၃ သ
ဋေ ၁.၀၆ သိန်း
Operating income
ဋေ ၁.၂၃ သ
ဋေ ၁.၈၇ သ
ဋေ ၁.၇၀ သ
ဋေ ၁.၂၉ သ
Other non operating income
-ဋေ ၂.၄၉ ထ
-ဋေ ၇.၈၀ ထ
ဋေ ၇.၈၀ ထ
-ဋေ ၂.၉၅ သ
EBT including unusual items
-ဋေ ၁.၀၇ သ
ဋေ ၁.၅၁ သ
ဋေ ၂.၈၂ ထ
ဋေ ၁.၃၄ သ
EBT excluding unusual items
ဋေ ၁.၀၀ သ
ဋေ ၁.၅၃ သ
ဋေ ၁.၂၉ သ
ဋေ ၁.၁၄ သ
Income tax expense
-၄၂၀.၁၀ ဋေ
ဋေ ၂.၆၄ ထ
ဋေ ၃.၉၉ ထ
ဋေ ၃.၀၁ ထ
Effective tax rate
၃.၉၂%
၁၇.၄၉%
၁၄၁.၆၄%
၂၂.၅၁%
Other operating expenses
-ဋေ ၉.၁၃ ထ
၆၀၃.၁၀ ဋေ
ဋေ ၁.၆၁ ထ
ဋေ ၆.၇၁ ထ
Net income
-ဋေ ၁.၀၃ သ
ဋေ ၁.၂၄ သ
-ဋေ ၁.၁၈ ထ
ဋေ ၁.၀၄ သ
Net profit margin
-၉.၇၉%
၁၁.၂၃%
-၁.၀၆%
၈.၇၀%
Earnings per share
-
-
-
-
Interest and investment income
၉၈၅.၄၀ ဋေ
ဋေ ၇.၃၈ ထ
ဋေ ၄.၃၉ ထ
ဋေ ၂.၇၉ သ
Interest expense
-၇၈၂.၂၀ ဋေ
-ဋေ ၂.၉၂ ထ
-ဋေ ၁.၆၁ သ
-
Net interest expenses
၂၀၃.၂၀ ဋေ
ဋေ ၄.၄၆ ထ
-ဋေ ၁.၁၇ သ
ဋေ ၂.၇၉ သ
Depreciation and amortization charges
-
-
-
-
EBITDA
ဋေ ၂.၂၂ သ
ဋေ ၃.၆၉ သ
ဋေ ၃.၅၅ သ
ဋေ ၁.၈၃ သ
Gain or loss from assets sale
-၂၃၈.၆၀ ဋေ
-ဋေ ၁.၇၃ ထ
၃၀.၃၀ ကုဋေ
၃၅.၈၀ ကုဋေ
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer